Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time
Vox Sanguinis, 10/06/09
Heger A et al. – The studies confirmed that the affinity ligand chromatography under the developed conditions can be introduced into the Octaplas manufacturing process, as a mean to reduce potentially present PrPSc, without hampering the proven quality of this product.
Today in Transfusion Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Tailoring iron chelation by iron intake and serum ferritin: prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
Haematologica, 12/09/09
Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort
Transfusion, 12/02/09
Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results
Transfusion, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


